Everest Medicines announced that it has made a strategic equity investment in I-Mab (IMAB). Rogers Yongqing Luo, CEO of Everest Medicines, said, “As a biotech pioneer in China, Everest has built ...
6d
I-Mab (IMAB) Discusses Business Transformation Strategy and Plans for Accelerated Growth Transcript
Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...
ZTS secures CVMP's positive opinion recommending the approval of Lenivia, a long-acting OA pain therapy for dogs, with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback